GI & Endoscopy

Here are six updates from gastroenterology companies and practices from the past week: 

Exact Sciences is a global cancer diagnostic company that was formed in 1995. Its flagship product, Cologuard, is a noninvasive colorectal cancer screening test that largely brought the company to where it is today.

Los Angeles-based Cedars-Sinai received a $25 million gift from a pair of private donors to support gastrointestinal treatments and advance research, the health system announced July 21.

Dallas-based GI Alliance partnered with Peoria-based Illinois Gastroenterology Institute, expanding its presence in Illinois and the Midwest.

Virginia Mason Bellevue (Wash.) Medical Center will open a 45,000-square-foot medical center July 27, the Downtown Bellevue Network reports.

The FDA approved Ambu's single-use duodenoscope July 17 as device companies continue creating scopes to decrease cross-contamination issues.

Southlake-based Texas Digestive Disease Consultants has a new ASC underway in Mansfield, according to MedCore Partners, a healthcare and medical real estate group involved in the development.

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of July 13-17:

Robert Wood Johnson University Hospital Somerset in Somerville, N.J., finished renovating its endoscopy suite, according to TAPinto.net.

Biopharmaceutical group Sosei Heptares closed a $200 million round of funding from an offering of new shares and euro-yen denominated convertible bonds.